DEA Whistleblower: Agent Alleges Fentanyl Protocols Prioritize Evidence Over Public Safety

Special Agent David Howell celebrated his 20th work anniversary with the Drug Enforcement Administration on August 20, 2026, while explaining to KOB 4 why he became a whistleblower against his own employer. Howell has spent his entire DEA career in New Mexico following a previous stint in the U.S. Navy. He stated that his primary motivation for challenging internal policies was a belief that the agency had strayed from its oath to protect the public.

Howell identified the rise of fentanyl as the catalyst for his concerns. He described the opioid as ten times more lethal and accessible than heroin. According to Howell, agents in the Albuquerque Field Division were instructed to follow the Department of Justice’s Operation Interdiction Protocol. The policy stated that protecting the public was paramount and superseded investigative goals. Howell alleged that in practice, the agency often prioritized case integrity over preventing fentanyl from reaching streets.

A specific incident in April 2023 crystallized Howell’s dissatisfaction. He and a partner conducted traffic stops based on intercepted wiretap information. They seized fentanyl and a loaded firearm from a vehicle that contained an elementary school-aged child. Howell claims supervisors reprimanded the agents, suggesting they had traumatized the child and stolen evidence. Howell noted that stopping a sale does not ruin a case.

Howell’s most serious allegations involve agents observing shipments without intervening. He described a situation where a vehicle carrying drugs arrived in Albuquerque from El Paso. When he asked a supervisor if the team would stop the vehicle, the answer was no. Howell photographed a woman unloading the car. He claims individuals connected to that apartment sold approximately 74,000 fentanyl pills that same night. When asked why agents used that approach, Howell quoted the response: “The investigation comes first.”

In August 2023, Howell filed a whistleblower complaint with the Department of Inspector General after repeated internal attempts failed. He alleges he faced immediate retaliation. Supervisors called him to El Paso and removed him from active investigations. Howell claimed the U.S. Attorney’s Office was concerned about his potential testimony regarding fentanyl movements in Albuquerque. His performance evaluations declined, and surveillance equipment was reassigned. He later relied on his iPhone for surveillance photos.

The DEA updated its fentanyl protocol in June 2024, granting agents more discretion. Howell argues the change worsened the issue. Two other agents in the Albuquerque office have also become whistleblowers. Howell remains employed by the DEA. When asked about the difficulty of his position, he said, “I’ve made a lot of enemies, but I just always go back to, what did I do wrong? What are we here for? All I did was tell the truth.” A DEA media spokesperson declined to comment on the active investigation.